Skip to main content

Beyond travel ban, Mylan sees no disruption to business in China

The pharmaceutical company, which is run from its global corporate center at Southpointe, is merging with a Pfizer Inc. unit that is based in China.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.